Efficacy and safety of Ginkgo biloba extract as an “add-on” treatment to metformin for patients with metabolic syndrome: a pilot clinical study

@inproceedings{Aziz2018EfficacyAS,
  title={Efficacy and safety of Ginkgo biloba extract as an “add-on” treatment to metformin for patients with metabolic syndrome: a pilot clinical study},
  author={Tavga Ahmed Aziz and Saad Abdulrahman Hussain and Taha Othman Asaad Mahwi and Zheen Aorahman Ahmed},
  booktitle={Therapeutics and clinical risk management},
  year={2018}
}
Background and aim Ginkgo biloba (GKB) extract has shown to be beneficial in experimental models of metabolic and inflammatory disorders such as diabetes and metabolic syndrome (MTS). The objective of this pilot clinical study was to evaluate the effects of GKB extract as an "add-on" treatment with metformin (Met) in MTS patients. Patients and methods We performed a randomized, placebo-controlled, double-blinded clinical study in subjects with MTS. Forty patients completed the 90-day clinical… CONTINUE READING
3
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects: a double-blind, placebo-controlled, crossover study

GB Kudolo, W Wanga, M Javorsb, J. Blodgettc
  • Clin Nutr
  • 2006
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL